Na Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Protease and Inhibitor Mechanisms
- MicroRNA in disease regulation
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
-
- Cancer-related molecular mechanisms research 21
- MicroRNA in disease regulation 20
- Protease and Inhibitor Mechanisms 8
-
- RNA modifications and cancer 13
- RNA Research and Splicing 8
- Circular RNAs in diseases 7
- Co-authors
- Wei Guo (3 shared papers)Jianhui Zhang (4 shared papers)Xia Jin (3 shared papers)Yan Li (2 shared papers)Yimin Wang (2 shared papers)Denggui Wen (2 shared papers)Lizhen Wei (2 shared papers)Shan Kang (3 shared papers)
- Journals
- Frontiers in Oncology (4 papers)Frontiers in Genetics (3 papers)Frontiers in Immunology (2 papers)Journal of Clinical Oncology (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Na Wang
94 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 537
- Oncology 245
- Molecular Biology 477
- Hematology 74
- Physiology 25
Countries citing papers authored by Na Wang
This map shows the geographic impact of Na Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Wang more than expected).
Fields of papers citing papers by Na Wang
This network shows the impact of papers produced by Na Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Wang. The network helps show where Na Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Na Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 138 | |
| 2 | 2005 | 106 | |
| 3 | 2005 | 73 | |
| 4 | 2005 | 33 | |
| 5 | 2019 | 29 | |
| 6 | 2012 | 26 | |
| 7 | 2009 | 23 | |
| 8 | 2013 | 23 | |
| 9 | 2015 | 23 | |
| 10 | 2022 | 22 | |
| 11 | 2013 | 22 | |
| 12 | 2019 | 21 | |
| 13 | 2016 | 19 | |
| 14 | Carcinoma-associated fibroblasts promote the proliferation and metastasis of osteosarcoma by transferring exosomal LncRNA SNHG17. | 2021 | 18 |
| 15 | 2022 | 18 | |
| 16 | 2019 | 18 | |
| 17 | The impact of hemoglobin level and transfusion on the outcomes of chemotherapy in gastric cancer patients. | 2015 | 18 |
| 18 | 2021 | 17 | |
| 19 | 2024 | 14 | |
| 20 | 2020 | 14 |
About Na Wang
Na Wang is a scholar working on Cancer Research, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Electrical and Electronic Engineering, having authored 113 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (21 papers), MicroRNA in disease regulation (20 papers), RNA modifications and cancer (13 papers), RNA Research and Splicing (8 papers), Protease and Inhibitor Mechanisms (8 papers), Circular RNAs in diseases (7 papers), Lung Cancer Research Studies (7 papers) and Ferroptosis and cancer prognosis (6 papers). The work is most often cited by research in Cancer Research (537 citations), Oncology (245 citations), Molecular Biology (477 citations), Hematology (74 citations) and Physiology (25 citations). Na Wang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Wei Guo, Jianhui Zhang, Xia Jin, Yan Li, Yimin Wang, Denggui Wen, Lizhen Wei, Shan Kang, Juan Wang and Ying Wang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Genetics, Frontiers in Immunology, Journal of Clinical Oncology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.